Equinixin Granules

Name:

 Equinixin Granules

Category:

 Anti-Inflammatories

Region:

 United Kingdom

White to cream coloured granules containing 250 mg flunixin, as flunixin meglumine per 10 gram sachet.

Flunixin meglumine is a relatively potent non-narcotic, non-steroidal analgesic with anti-inflammatory and anti-pyretic properties.

In the horse, Equinixin Granules are indicated for the alleviation of inflammation and pain associated with musculo-skeletal disorders.

Equinixin Granules is indicated for oral administration to horses.
Easily administered by sprinkling on a small amount of food.
Add to feed immediately before administration. Discard any remaining medicated feed.

Dosage:
The recommended dosage is the contents of one sachet (10 grams) Equinixin Granules per 227 kg (500 lb) bodyweight (equivalent to 1.1 mg flunixin per kg) once daily for up to 5 consecutive days according to clinical response.

Do not administer the product to pregnant mares.
Do not administer other non-steroidal anti-inflammatory drugs (NSAIDs) concurrently or within 24 hours of each other. Some NSAIDs may be highly bound to plasma proteins and compete with other highly bound drugs which can lead to toxic effects.
Concurrent administration of potentially nephrotoxic drugs should be avoided.
It is preferable that NSAID’s which inhibit prostaglandin synthesis are not administered to animals undergoing general anaesthesia until fully recovered.
Use is contraindicated in animals suffering from cardiac, hepatic or renal disease, where there is the possibility of gastrointestinal ulceration or bleeding, where there is evidence of a blood dyscrasia or hypersensitivity to the product.
Do not exceed the recommended dose or the duration of treatment.
Use in any animal less than 6 weeks of age or in aged animals may involve additional risk. If such use cannot be avoided animals may require a reduced dosage and careful clinical management.
Avoid use in any dehydrated, hypovolaemic or hypotensive animals, as there is a potential risk of increased renal toxicity.
Horses intended for racing and competition should be prevented from racing or competing when in need of treatment and horses which have been recently treated should be dealt with according to local requirements. Appropriate precautions must be taken to ensure compliance with competition regulations.

Avoid inhalation, contact with eyes and direct contact with skin.
In case of spillage onto skin wash immediately with water.
In the case of accidental contact with eyes, rinse immediately with plenty of water and seek medical advice.
To avoid possible sensitisation reactions, avoid contact with the skin. Gloves should be worn during application. Wash hands after use.
The product may cause reactions in sensitive individuals. If you have known hypersensitivity for non-steroidal anti-inflammatory products do not handle the product. Reactions may be serious.
Overdosage is associated with gastrointestinal toxicity.

Horses may be slaughtered for human consumption only after 7 days from the last treatment.

Dispose of any unused product and empty containers in accordance with guidance from your local waste regulation authority.

Do not store above 25°C.
Store out of reach of children.

POM-V
To be supplied only on veterinary prescription

10 gram laminated foil sachets containing white to cream coloured granules.

Cartons of 10 sachets, each sachet containing 250 mg of Flunixin.

Norbrook Laboratories Limited
Station Works
NEWRY
Co. Down, BT35 6JP
Northern Ireland

ML: 2000/01
Vm: 02000/4241

FOR ANIMAL TREATMENT ONLY.
UK authorised Veterinary Medicinal Product